Congo Approves Clinical Trials for Novel Oral Ebola Treatment

Kinshasa, Monday, 13 July 2026.
As Ebola spreads in Congo, NanoViricides secured approval for Phase II trials of NV-387, a novel treatment uniquely formulated as oral gummies to simplify epidemic response.